Institut für Klinische Chemie und Laboratoriumsmedizin
Klinikum / Johannes Gutenberg-Universität Mainz
Tsimikas, S; Aikawa, M; Miller, FJ et al.
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering. A potential biomarker of early atherosclerosis regression.Arterioscler Thromb Vasc Biol. Bd. 27. 2007 S. 175-181
Espinola-Klein, C; Rupprecht, HJ; Bickel, C et al.
Inflammation, atherosclerotic burden and cardiovascular prognosis.Atherosclerosis. Bd. 195. H. 2. 2007 S. e126-34
Reifenberg, K; Lehr, HA; Torzewski, M et al.
Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.Am J Pathol. Bd. 171. H. 2. 2007 S. 463-72
Lackner, KJ
Krankheiten durch Störungen des Fettstoffwechsels.Gerok, Huber, Meinertz, Zeidler (Hrsg). Die Innere Medizin. 11. Aufl. Stuttgart: Schattauer Verlag 2007
Lackner, KJ; Schmitz, G
Labordiagnostik der DyslipoproteinämienSchwandt P, Parhofer KG (Hrsg). Handbuch der Fettstoffwechselstörungen. 3. Aufl. Stuttgart: Schattauer Verlag 2007
Lehmann, WD; Kruger, R; Salek, M et al.
Neutral loss-based phosphopeptide recognition: a collection of caveats.J Proteome Res. Bd. 6. H. 7. 2007 S. 2866-73
Buhl, A; Metzger, JH; Heegaard, NH et al.
Novel Biosensor-Based Analytic Device for the Detection of Anti-Double-Stranded DNA Antibodies.Clin Chem. Bd. 53. 2007 S. 334-341
Wenzel, JJ; Rossmann, H; Lackner, KJ et al.
Novel human pathological mutations. Gene symbol: MEN1. Disease: MEN1, Multiple endocrine neoplasia, type 1.Hum Genet. Bd. 122. H. 3-4. 2007 S. 416
von Landenberg, P; Bauer, S
Nucleic acid recognizing Toll-like receptors and autoimmunity.Curr Opin Immunol. Bd. 19. H. 6. 2007 S. 606-10
Wenzel, P; Hink, U; Oelze, M et al.
Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.Br J Pharmacol. Bd. 150. H. 4. 2007 S. 526-33